Hepatic Progenitor Cells Contribute To The Progression Of 2-Acetylaminofluorene/Carbon Tetrachloride-Induced Cirrhosis Via The Non-Canonical Wnt Pathway
jiamei chen,xiao zhang,ying xu,xuewei li,shuang ren,yaning zhou,yuyou duan,mark a zern,hua zhang,gaofeng chen,chenghai liu,yongping mu,ping liu
DOI: https://doi.org/10.1371/journal.pone.0130310
IF: 3.7
2015-01-01
PLoS ONE
Abstract:Hepatic progenitor cells (HPCs) appear to play an important role in chronic liver injury. In this study, cirrhosis was induced in F-344 rats (n = 32) via subcutaneous injection of 50% carbon tetrachloride (CCl4) twice a week for 8 weeks. Then, 30% CCl4 was administered in conjunction with intragastric 2-acetylaminofluorine (2-AAF) for 4 weeks to induce activation of HPCs. WB-F344 cells were used to provide direct evidence for differentiation of HPCs to myofibroblasts. The results showed that after administration of 2-AAF, the hydroxyproline content and the expressions of alpha-SMA, Col I, Col IV, TGF-beta 1, CD68, TNF-alpha, CK19 and OV6 were significantly increased. OV6 and alpha-SMA were largely co-expressed in fibrous septum and the expressions of Wnt5b, frizzled2, frizzled3 and frizzled6 were markedly increased, while beta-catenin expression was not statistically different among the different groups. Consistent with the above results, WB-F344 cells, treated with TGF-beta 1 in vitro, differentiated into myofibroblasts and alpha-SMA, Col I, Col IV, Wnt5b and frizzled2 expressions were significantly increased, while beta-catenin expression was decreased. After blocking the non-canonical Wnt pathway via WIF-1, the Wnt5b level was down regulated, and a-SMA and F-actin expressions were significantly decreased in the WIF-1-treated cells. In conclusion, these results indicate that HPCs appear to differentiate into myofibroblasts and exhibit a profibrotic effect in progressive cirrhosis via activation of the non-canonical Wnt pathway. Blocking the non-canonical Wnt pathway can inhibit the differentiation of HPCs into myofibroblasts, suggesting that blocking this pathway and changing the fate of differentiated HPCs may be a potential treatment for cirrhosis.